1.72 USD
↗ 0.04 (2.38%)AT CLOSE (11:59 AM EDT)
NervGen Pharma Corp. Common stock
NGENNASDAQ • USD
1.70
↘ 0.02 (1.16%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
1.70
↘ 0.02 (1.16%)
Market: CLOSED
NervGen Pharma Corp. Common stock (NGEN) trades at $1.72 per share. Technical indicators currently signal "Sell". This is driven by a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Aug 6, 2026.
Open?$1.68
High?$1.76
Low?$1.66
Prev. Close?$1.68
Volume?343.6K
Avg. Volume?N/A
VWAP?$1.72
Bid / Ask
Bid?$1.47 × 100
Ask?$1.95 × 100
Spread?$0.48
Midpoint?$1.71
Valuation & Ratios
Market Cap?178.8M
Shares Out?80.6M
Float?63.9M
Float %?79.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?7.06%Elevated
Short Interest?4.5M
Days to Cover?5.2
Free Float63.9M
Avg Daily Volume862.1K
Settlement Date2026-07-15